ACCENDRA HEALTH INC/VA/ (ACH): debt financing — Owens & Minor closes $1B 10% senior secured notes offering to fund Rotech acquisition

ACCENDRA HEALTH INC/VA/

$1,000,000,000 aggregate principal of 10.000% senior secured notes due 2030 issued.
Proceeds held in escrow pending consummation of acquisition of Rotech Healthcare Holdings Inc.
Special mandatory redemption if acquisition not completed by October 6, 2025, at 100% plus accrued interest.
Notes secured by first-priority lien on escrow; after acquisition, secured by substantially all assets of company and guarantors.
Restricted covenants apply; investment grade rating would suspend most covenants.

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.98

ACCENDRA HEALTH INC/VA/ incurred senior notes of $1,000,000,000 aggregate principal amount with Regions Bank at 10.000% per year maturing due 2030.

Instrument: senior notes
Principal: $1,000,000,000 aggregate principal amount
Counterparty: Regions Bank
Rate: 10.000% per year
Maturity: due 2030
Event: incurrence

Exact text from the filing

On April 4, 2025, Owens & Minor, Inc. (the “Company”), completed its previously announced sale of $1,000,000,000 aggregate principal amount of the Company’s 10.000% senior secured notes due 2030 (the “New Notes”) in a private offering (the “Offering”) that is exempt from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”).

View on SEC.gov

Browse all debt financings →

ACCENDRA HEALTH INC/VA/ filing history →

Source: SEC EDGAR

accession 0001193125-25-073544

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.